YC

Yuansheng Capital

Asia, Jiangsu, China, Suzhou

Description

Yuansheng Capital is a new venture firm established by former Tencent Holding Ltd. executive Peng Zhijian in 2015.

Investor Profile

Yuansheng Capital has backed more than 5 startups, with 2 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series F, Series A, Series C rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biotechnology, Consulting, Recruiting.

Stage Focus

  • Series F (20%)
  • Series A (20%)
  • Series C (20%)
  • Series Unknown (20%)
  • Series B (20%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Consulting
  • Recruiting
  • Health Care
  • E-commerce
  • E-commerce Platforms
  • Logistics
  • Real Estate
  • Cooking
  • Service Industry
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Yuansheng Capital frequently co-invest with?

Shenzhen Guozhong Venture Capital Management
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Jingwei Investments
Asia, Guangdong, China, Shenzhen
Co-Investments: 2
Goldman Sachs
North America, New York, United States, New York
Co-Investments: 1
SoftBank Vision Fund
Europe, England, United Kingdom, London
Co-Investments: 2
Future Capital
Europe, Hessen, Germany, Frankfurt
Co-Investments: 1
Matrix Partners China
Asia, Beijing, China, Beijing
Co-Investments: 2
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 1
Fidelity International
Europe, England, United Kingdom, London
Co-Investments: 1
BioVenture
Asia, Jiangsu, China, Suzhou
Co-Investments: 2
Primavera Capital Group
Asia, Beijing, China, Beijing
Co-Investments: 1

What are some of recent deals done by Yuansheng Capital?

Hailai Technology is a biotechnology business that specializes in research and development.

BiopharmaBiotechnologyClinical TrialsLife Science
AngelDec 24, 2025
Amount Raised: $8,538,859
AusperBio

Hangzhou, Zhejiang, China

AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.

BiopharmaBiotechnologyPharmaceutical
Series BMay 28, 2025
Amount Raised: $50,000,000
Carrot

Hangzhou, Zhejiang, China

Carote is a well-known brand of home cookware, including cooking pots and water utensils.

CookingService Industry
Series UnknownSep 23, 2024
Amount Raised: $40,000,000
Xiaopangxiong

Shanghai, Shanghai, China

Xiaopangxiong provides business to business trading platform intended to sell and buy home construction materials.

E-CommerceE-Commerce PlatformsLogisticsReal Estate
Series CJun 7, 2021
Amount Raised: $400,000,000
Beisen

Beijing, Beijing, China

Beisen provides talent management and measurement solutions.

ConsultingRecruiting
Series FMay 11, 2021
Amount Raised: $260,000,000
Ruixun Biotech

Suzhou, Jiangsu, China

Ruixun Biotech is a healthcare company that provides biotechnology.

BiotechnologyHealth Care
Series ASep 26, 2019

Find More Investors Like Yuansheng Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Yuansheng Capital | Pipeseed